« Previous
Next »
The American Journal of Pathology
Volume 180, Issue 3
, Pages 1080-1094
, March 2012
Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets
To access this article, please choose from the options below
Supported by grants from the Scleroderma Research Foundation (M.L.W., A.O.A. and L.H.G.), a Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation (M.L.W.), a Career Award for Medical Scientists from the Burroughs Wellcome Fund (A.O.A.), by an NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases grant K08AR054859 (A.O.A), NIAMS grants U01AR055063 (R.L.) and R01AR051089 (R.L.), and by Scleroderma Foundation support (G.F.).
M.B.G. and J.L.S. contributed equally to the present work.
Disclosures: L.H.G. is a member of the board of directors of and holds equity in Bristol Myers Squibb and receives research funds from Merck & Co. M.L.W. is a scientific founder and holds a financial interest in Celdara Medical, LLC. The other authors declare no conflicts of interest.
The content of this manuscript is solely the responsibility of the authors and does not represent the official views of NIAMS or the NIH.
Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.11.024.
Current address of J.L.S., NIH-NIAMS, Bethesda, Maryland; of L.H.G., Weill Cornell Medical College, New York, New York.
PII: S0002-9440(11)01088-1
doi: 10.1016/j.ajpath.2011.11.024
© 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Pathology
Volume 180, Issue 3
, Pages 1080-1094
, March 2012
